11th Annual eyeforpharma Philadelphia 2013 The customer centric pharma business is all about people, technology and channel effectiveness June 5 - 7, 2013 * Philadelphia, PA
Real World Evidence 2013 Provide robust evidence on the real world value of treatments to transform healthcare June 6 - 7, 2013 * Bethesda, MD
Medical Behavior in a Commercial World: Who is Responsible? Exploring the ethical responsibilities of health care providers, medical journals, industry, and payers on therapeutic choices. June 6 - 7, 2013 * Georgetown University, Washington, DC
Doctors 2.0 & You The major event in Europe for all people interested in Health and Medicine 2.0 and Social Media June 6 - 7, 2013 * Paris, France Tweets about "#doctors20"
4th Annual Digital Pharma West Drive Innovation into Integrated Digital Strategy and Realize Returns Across Brands June 24 - 27, 2013 * South San Francisco, CA
Patient Engagement, Support & Adherence Increase Patient Compliance, Improve Health Outcomes & Lower Costs Through The Latest Digital Strategies July 29 - 31, 2013 * New York, NY Pharmaguy will moderate the panel "Understanding The Rules Of Engagement For Managing Patient Support & Adherence: Social Media, Gaming, & Mobile Technology." Mention "PharmaMarketing News" to receive a special $200 discount!
3rd Annual Pharma eMarketing Congress 12 - 13 September 2013 * Barcelona, Spain Pharmaguy will lead the workshop: "Social media & the pharma industry -- a turbulent marriage."
Selected Content from Most Recent Issue of Pharma Marketing News
Mobile Medical App Guidance & Beyond!
Keeping Up with Technology, Enforcement Headaches, and Still More FDA Guidance
In July, 2011, FDA's Center for Devices and Radiological Health and the Center for Biologics Evaluation and Research, which is responsible for regulating medical devices, issued DRAFT guidance for mobile medical applications. The mobile industry as well as the medical device and drug industries have commented on the draft guidance and are anxiously awaiting the final guidance. The nearly 2-year delay may have been part of the reason for the recent House Subcommittee on Oversight and Investigations hearing regarding "Health Information Technologies: Administration Perspectives on Innovation and Regulation."
Many experts and industry representatives testified at these hearings, including Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition. Thompson was also interviewed by Pharma Marketing News.
This article is a review of Thompson's testimony and interview. It covers the prospects for FDA's final guidance on regulation of MMAs and other regulatory issues that the mobile health community and FDA will likely face after publication of the "final" guidelines.
The full text of this article is available to subscribers. Subscription is free.
Each issue of Pharma Marketing News is packed with facts,
opinions, and case studies based upon interviews with experts in
the field of pharmaceutical marketing. Highlights of presentations
from industry conferences and links to references help subscribers keep up to date on best
practices and network with their peers.
Use this Form to request a listing for your conference or event
Pharmaguy will moderate the panel "Understanding The Rules Of Engagement For Managing Patient Support & Adherence: Social Media, Gaming, & Mobile Technology." Mention "PharmaMarketing News" to receive a special $200 discount!
